John Henderson
Wnt antagonist DKK‐1 levels in systemic sclerosis are lower in skin but not blood and is regulated by microRNA33a‐3p
Henderson, John; Pryzborski, Stefan; Stratton, Richard; O’Reilly, Steven
Authors
Stefan Pryzborski
Richard Stratton
Steven O’Reilly
Contributors
Professor Stefan Przyborski stefan.przyborski@durham.ac.uk
Other
Abstract
Background: Systemic sclerosis is an autoimmune skin disease which is associated with inflammation and resulting skin fibrosis. Myofibroblasts are the key cell type associated with the fibrosis but how they are differentiated is not clear. DKK‐1 is a Wnt antagonist that blocks Wnt‐mediated fibrosis and is reduced in fibrotic conditions. Thus DKK‐1 is a clear negative regulator of fibrosis in systemic sclerosis and its regulation is unknown.The aim of this work is to determine the levels of DKK‐1 in serum and tissues of SSc and its regulation. Methods: Skin biopsies were taken from early diffuse systemic sclerosis patients and healthy controls and DKK‐1 measured by ELISA; serum was also isolated and DKK‐1 quantified. DKK‐1 was also measured by qRT‐PCR. MicroRNA33a‐3p was measured by Taqman PCR. miR mimics and controls were transfected into dermal fibroblasts. Bleomycin mouse model was employed and compared to vehicle control treated mice and gene expression was employed for DKK‐1 and various extracellular matrix genes. Results: DKK‐1 is reduced in SSc skin and fibroblasts but is not reduced in the circulation in patients. microRNA33a‐3p regulates DKK‐1 levels epigenetically and is significantly reduced in SSc cells and whole tissue. DKK‐1 is also reduced in the bleomycin mouse modelandpro‐fibrotic genes elevated. Conclusion: DKK‐1 is reduced in SSc cells and is regulated by miR33a‐3p and restoring DKK‐1 levels through epigenetic means could be a therapeutic target in systemic sclerosis.
Citation
Henderson, J., Pryzborski, S., Stratton, R., & O’Reilly, S. (2020). Wnt antagonist DKK‐1 levels in systemic sclerosis are lower in skin but not blood and is regulated by microRNA33a‐3p. Experimental Dermatology, 30(1), 162-168. https://doi.org/10.1111/exd.14136
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 22, 2020 |
Online Publication Date | Sep 10, 2020 |
Publication Date | 2020 |
Deposit Date | Jul 2, 2020 |
Publicly Available Date | Sep 16, 2020 |
Journal | Experimental Dermatology |
Print ISSN | 0906-6705 |
Electronic ISSN | 1600-0625 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 30 |
Issue | 1 |
Pages | 162-168 |
DOI | https://doi.org/10.1111/exd.14136 |
Files
Published Journal Article (Advance online version)
(739 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Copyright Statement
Advance online version © 2020 The Authors. Experimental Dermatology published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
You might also like
Generation of a novel three-dimensional scaffold-based model of the bovine endometrium
(2023)
Journal Article
Downloadable Citations
About Durham Research Online (DRO)
Administrator e-mail: dro.admin@durham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search